LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease ; volume:11 ; number:1 ; day:31 ; month:1 ; year:2022 ; pages:1-14 ; date:12.2022
Translational neurodegeneration ; 11, Heft 1 (31.1.2022), 1-14, 12.2022
- Creator
-
Pang, Shirley Yin-Yu
Lo, Rachel Cheuk Nam
Ho, Philip Wing-Lok
Liu, Hui-Fang
Chang, Eunice Eun Seo
Leung, Chi-Ting
Malki, Yasine
Choi, Zoe Yuen-Kiu
Wong, Wing Yan
Kung, Michelle Hiu-Wai
Ramsden, David Boyer
Ho, Shu-Leong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-022-00281-6
- URN
-
urn:nbn:de:101:1-2022050820433892646168
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pang, Shirley Yin-Yu
- Lo, Rachel Cheuk Nam
- Ho, Philip Wing-Lok
- Liu, Hui-Fang
- Chang, Eunice Eun Seo
- Leung, Chi-Ting
- Malki, Yasine
- Choi, Zoe Yuen-Kiu
- Wong, Wing Yan
- Kung, Michelle Hiu-Wai
- Ramsden, David Boyer
- Ho, Shu-Leong
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Dual-Task Performance in GBA Parkinson’s Disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
GBA mutations and Parkinson's disease in Brazil
Dual-Task Performance in GBA Parkinson's Disease
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 in Parkinson's disease and dementia with Lewy bodies
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Dual-Task Performance in GBA Parkinson’s Disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
GBA mutations and Parkinson's disease in Brazil
Dual-Task Performance in GBA Parkinson's Disease
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 in Parkinson's disease and dementia with Lewy bodies
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Dual-Task Performance in GBA Parkinson’s Disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
GBA mutations and Parkinson's disease in Brazil
Dual-Task Performance in GBA Parkinson's Disease
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition